Skip to content

Evaluating nursing care to reduce nasal injury in premature babies on nCPAP

Evaluation of Nurse-led standard nasal Continuous Positive Airway Pressure (nCPAP) care bundle on reducing the nCPAP-related nasal injury in preterm neonates using a Quasi Experimental Study in a level III Neonatal Intensive Care Unit of a tertiary hospital in Bhutan. - nCAPP-NI in premature neonates

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061882
Enrollment
53
Registered
2026-06-11
Start date
2026-06-15
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasal injury in preterm neonates receiving nasal Continuous Positive Airway Pressure (nCPAP)

Interventions

Observation (Control) group: All the premature neonates admitted in the phase I period who receive nCPAP will be enrolled. They will be observed for 2 months using usual practice. Intervention group:

Sponsors

Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. All preterm neonates (before 37 completed weeks of gestation). 2. Preterm with Birth Weight of 600 gm to <2500 gm. 3. Preterm requiring nCPAP for more than 4 hours. 4. Preterm neonates whose parent or guardian consents to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Preterm neonates with congenital anomalies (diaphragmatic hernia, tracheoesophageal atresia, spina bifida, Edward syndrome) and skin diseases (epidermolysis bullosa, impetigo). 2. Preterm neonates with old scar or nasal injury (previously exposed). 3. Readmitted preterm neonates who were involved in the study previously.

Design outcomes

Primary

MeasureTime frame
Incidence of nCPAP related nasal injury

Secondary

MeasureTime frame
1. Severity of nasal injury 2. Time of first injury 3. Adherence to care bundle

Countries

Asia(except Japan)

Contacts

Public ContactYeshey Tshomo

Hiroshima University Graduate School of Biomedical and Health Science, Hiroshima University

yetsho.jks09@gmail.com70-9228-4863

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026